Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment ParadigmsChristopher Chang, Joshua D. Bernstock, Debora Mazzetti et al.|International Journal of Molecular Sciences|2024Cited by 32
Gabapentinoids confer survival benefit in human glioblastomaJoshua D. Bernstock, Shawn L. Hervey‐Jumper, Mulki Mehari et al.|Nature Communications|2025Cited by 15
Recent oncolytic virotherapy clinical trials outline a roadmap for the treatment of high-grade gliomaJoshua D. Bernstock, Gregory K. Friedman, Sarah E. Blitz et al.|Neuro-Oncology Advances|2023Cited by 13
Next-generation CAR T cell therapies for glioblastomaJoshua D. Bernstock, E. Antonio Chiocca, Jakob V. E. Gerstl et al.|Science Translational Medicine|2024Cited by 9
Positioning SUMO as an immunological facilitator of oncolytic viruses for high-grade gliomaParamesh Karandikar, Joshua D. Bernstock, Lyle Suh et al.|Frontiers in Cell and Developmental Biology|2023Cited by 5